Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Armata Pharmaceuticals Inc. sell ReynadJ

Start price
€2.00
21.08.24 / 0%
Target price
-
21.08.25
Performance (%)
3.00%
End price
€2.06
22.08.25
Summary
This prediction ended on 22.08.25 with a price of €2.06. The SELL prediction by ReynadJ shows the price for Armata Pharmaceuticals Inc. slightly increased by 3.00% during the runtime of the prediction. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Armata Pharmaceuticals Inc. -2.178% -2.178% -
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

According to ReynadJ what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?

Pros
Cons
Bad rating
Little Investments for future growth
Probably not worthwhile Investment
negative Cash Flow expected
Lower EBIT Margin than peer group
Revenue decline/stagnation expected

Comments by ReynadJ for this prediction

In the thread Armata Pharmaceuticals Inc. diskutieren

Sell Armata Pharmaceuticals Inc.

In the thread Trading Armata Pharmaceuticals Inc.
Prediction Sell
Perf. (%) 3.00%
Target price
Change
Ends at 21.08.25

Die von ReynadJ gewählte maximale Laufzeit wurde überschritten